Skip to content
Delayed
PDI $14.36 ▼0.17%D 2.9%DXYZ $28.12 ▼2.66%D 18.0%GOF $8.53 ▼1.10%D 14.2%VCX $24.94 ▼1.30%D 34.6%NEA $10.12 ▲0.75%D 1.1%PTY $10.72 ▼1.02%D 1.3%CLM $6.17 ▼1.36%D 1.6%NAD $10.43 ▲0.92%D 1.4%BCAT $12.99 ▼1.14%D 12.9%JPC $6.83 ▲0.59%D 7.5%PDO $11.86 ▼0.80%D 2.6%UTG $35.20 ▲0.43%D 1.0%BPRE $12.43 ▼0.48%D 47.2%NVG $10.92 ▲0.60%D 1.3%NZF $11.04 ▲0.41%D 0.9%BOT $25.12 ▼3.86%P 242.2%NMZ $9.13 ▲0.05%D 0.5%NAC $10.12 ▼0.15%D 2.0%CRF $5.89 ▼0.76%D 3.4%OXLC $8.08 ▼1.04%MQY $10.32 ▲1.13%D 6.1%UTF $25.62 ▲0.31%D 2.7%ECAT $13.37 ▼1.36%RQI $11.23 ▲0.49%D 7.4%HYT $7.73 ▼0.45%D 11.3%NUV $8.26 ▲0.15%D 3.7%DNP $10.00 ▲1.53%P 8.2%USA $5.93 ▼0.92%D 12.0%ADX $25.64 ▼0.78%D 3.5%MHD $10.46 ▲0.77%D 8.3%DSL $9.79 ▼0.15%D 9.7%MUC $9.70 ▼0.05%D 8.6%TYG $38.90 ▲1.07%D 8.7%MYI $9.83 ▲0.51%D 7.0%JFR $7.31 ▼0.27%D 10.4%BSTZ $27.51 ▼1.22%PCN $10.66 ▼0.14%D 1.8%ASGI $19.34 ▼0.15%D 8.9%EVV $8.37 ▲0.18%D 12.0%PHK $4.07 ▼0.25%D 4.3%

Which closed-end funds own Indivior Pharmaceuticals Inc?

11 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $32.3M. Security type: debt security. Country: United States. CUSIP 45579UAA7 · ISIN US45579UAA79.

Holdings are historical filings (report dates May 29, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.

Funds holding this security

FundCategoryWeightValue (USD)BalanceFund net assetsPrem/discReport date
CCD Calamos Dynamic Convertible & Income FundConvertible Securities0.51%$4.8M4,000,000 par$939M6.7% premiumJul 31, 2026
CHI Calamos Convertible Opportunities & Income FundConvertible Securities0.42%$5.7M4,750,000 par$1.4B4.5% premiumJul 31, 2026
CHY Calamos Convertible & High Income FundConvertible Securities0.41%$6M5,000,000 par$1.5B0.3% premiumJul 31, 2026
NCZ Virtus Convertible & Income Fund IIConvertible Securities0.38%$1.8M1,485,000 par$463M7.6% discountJul 31, 2026
NCV Virtus Convertible & Income FundConvertible Securities0.37%$2.2M1,860,000 par$601M9.6% discountJul 31, 2026
ACV Virtus Diversified Income & Convertible FundConvertible Securities0.35%$1.3M1,105,000 par$380M5.3% discountJul 31, 2026
AVK Advent Convertible & Income FundConvertible Securities0.32%$2.4M2,007,000 par$757MNAV unavailableJul 31, 2026
NIE Virtus Equity & Convertible Income FundConvertible Securities0.22%$1.8M1,475,000 par$786M9.5% discountJul 31, 2026
NFJ Virtus Dividend, Interest & Premium Strategy FundU.S. Equity0.12%$1.8M1,470,000 par$1.5B9.0% discountJul 31, 2026
CSQ Calamos Strategic Total Return FundMulti-Asset0.10%$4.7M3,897,000 par$4.9B9.4% discountJul 31, 2026
VGI Virtus Global Multi-Sector Income FundMulti-Asset0.01%$13.5K12,000 par$129M10.8% discountMay 29, 2026

11 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.

Also listed in filings as: INDIVIOR PHARMACEUTICALS.

Related securities from the same issuer

SecurityTypeFunds holding
Indivior Pharmaceuticals Inccommon equity1

Issuer-level search for “INDIVIOR PHARMACEUTICALS INC” → · Compare two funds’ portfolios →